Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy or have mild or moderate renal impairment.
Females must be of non-childbearing potential(hysterectomy, bilateral oophorectomy, post-menopausal) OR childbearing and must have a negative pregnancy test and meet/comply with one of the following: abstinence, double-barrier contraception, vasectomized partner).
Be negative for Hepatitis B and C.
Have negative results on drug, alcohol and HIV tests.
Have stable renal function.
You may not be if
Have a peptic ulcer.
Abuse drugs or alcohol.
Are pregnant or lactating.
Have heart failure.
Have uncontrolled emesis.
Have an infection.
Have taken or received inducers or inhibitors of CYP3A4 or CYP3A5 within 14 days of study start.
Active peptic ulcer disease.
Digoxin use.
Laboratory results that show low iron or pepsinogen levels, AST and CK level \>1,5 ULN, or that show stool is positive for occult blood.
Clareo Health | Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
